Mesenchymal stem cells in patients with chronic myelogenous leukaemia or Bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone

Anticancer Research

Volumn 27, Issue 6 B, 2007, Pages 3837-3841

  Wöhrer, Stefan ^a,b   Rabitsch, W ^a   Shehata, M ^a   Kondo, R ^a   Esterbauer, H ^a   Streubel, B ^a   Sillaber, C ^a   Raderer, M ^a   Jaeger, U ^a   Zielinski, C ^a   Valent, P ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

BCR ABL gene; Chronic myelogenous leukaemia; Fusion protein; Mesenchymal stem cells; Philadelphia chromosome

Indexed keywords

BCR ABL PROTEIN;

ACUTE LEUKEMIA; ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MACROPHAGE; MESENCHYMAL STEM CELL; MOLECULAR CLONING; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CELL GROWTH PROCESSES; CHROMOSOME ABERRATIONS; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MESENCHYMAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 37549013689     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147, 1999.
2. Majumdar MK, Thiede MA, Mosca JD, Moorman M and Gerson SL: Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176(1): 57-66, 1998.
3. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC: Gastric cancer originating from bone marrow-derived cells. Science 306(5701): 1568-1571, 2004.
4. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA and Verfaillie CM: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893): 41-49, 2002.
5. Deininger MW, Goldman JM and Melo JV: The molecular biology of chronic myeloid leukemia. Blood 96(10): 3343-3356, 2000.
6. Kabarowski JH and Witte ON: Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells 18(6): 399-408, 2000.
7. Nowell PC and Hungerford DA: Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25: 85-109, 1960.
8. Gunsilius E, Duba HC, Petzer AL, Kahler CM, Grunewald K, Stockhammer G, Gabl C, Dirnhofer S, Clausen J and Gastl G: Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells. Lancet 355(9216): 1688-1691, 2000.
9. Fang B, Zheng C, Liao L, Han Q, Sun Z, Jiang X and Zhao RC: Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics. Blood 105(7): 2733-2740, 2005.
10. Carrara RC, Orellana MD, Fontes AM, Palma PV, Kashima S, Mendes MR, Coutinho MA, Voltarelli JC and Covas DT: Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant. Braz J Med Biol Res 40(1): 57-67, 2007.
11. Jootar S, Pornprasertsud N, Petvises S, Rerkamnuaychoke B, Disthabanchong S, Pakakasama S, Ungkanont A and Hongeng S: Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. Leuk Res 30(12): 1493-1498, 2006.
12. Fonatsch C and Streubel B: Classical and molecular cytogenetics. Berlin: Springer; pp. 113-141, 1998.
13. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B and Green AR: Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95(3): 738-743, 2000.
14. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U, Heinze B, Fonatsch C, Harbott J, Reiter A et al: Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 337(8749): 1055-1058, 1991.
15. Mitterbauer G, Fodinger M, Scherrer R, Knobl P, Jager U, Laczika K, Schwarzinger I, Gaiger A, Geissler K, Greinix H et al: PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. Br J Haematol 89(4): 937-941, 1995.
16. Justesen J, Stenderup K, Eriksen EF and Kassem M: Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures. Calcif Tissue Int 71(1): 36-44, 2002.
17. Sheehan D and Hrapchak B: Theory and Practice of Histotechnology. 2nd ed. Ohil: Battelle Press; pp. 226-227, 1980.
18. Bhatia R, McGlave PB, Dewald GW, Blazar BR and Verfaillie CM: Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages. Blood 85(12): 3636-3645, 1995.
19. Brunning R, Matutes E, Borowitz M, Flandrin G, Head D, Vardiman J and Bennett J: Acute leukaemias of ambiguous lineage. Lyon: IARC Press; pp. 106-107, 2001.
20. Simmons PJ, Przepiorka D, Thomas ED and Torok-Storb B: Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328(6129): 429-432, 1987.
21. Hongeng S, Petvises S, Rerkamnuaychoke B, Worapongpaiboon S, Tardtong P, Apibal S and Ungkanont A: Host origin of marrow mesenchymal stem cells following allogeneic cord-blood stem-cell transplantation. Int J Hematol 74(2): 235-236, 2001.
22. Le Blanc K: Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8(6): 559-561, 2006.